Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Erika Carmel-TechXTAE:ERKA 32 Days Payable is 506.96 as of Dec. 2025, which is 69% above its 10-year median of 299.13. GuruFocus rates XTAE:ERKA with a GF Score™ of 32/100 and a GF Value™ of ₪0.55 (Fairly Valued). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Erika Carmel-Tech ranks better than 89.17% on this metric.
The historical rank and industry rank for Erika Carmel-Tech's Days Payable or its related term are showing as below:
XTAE:ERKA'
s Days Payable Range Over the Past 10 Years
Min: 136.84 Med: 299.13 Max: 422.75
Current: 303.67
During the past 8 years, Erika Carmel-Tech's highest Days Payable was 422.75. The lowest was 136.84. And the median was 299.13.
XTAE:ERKA's Days Payable is ranked better than 89.17% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs XTAE:ERKA: 303.67
Erika Carmel-Tech's Days Payable
increased
from Dec. 2024 (254.80) to Dec. 2025 (506.96).
It may suggest that Erika Carmel-Techdelayed paying its suppliers.
Erika Carmel-Tech Days Payable Related Terms
Erika Carmel-Tech Days Payable Historical Data
* Premium members only.
The historical data trend for Erika Carmel-Tech's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:ERKA vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Erika Carmel-Tech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Erika Carmel-Tech Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Erika Carmel-Tech's Days Payable distribution charts can be found below:
* The bar in red indicates where Erika Carmel-Tech's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Erika Carmel-Tech's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Erika Carmel-Tech (XTAE:ERKA) has a Days Payable of 506.96 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Erika Carmel-Tech and its competitors. This is 69% above median its historical median of 299.13. Over the past decade, Erika Carmel-Tech's Days Payable has ranged from 136.84 to 422.75. According to the industry distribution chart, Erika Carmel-Tech ranks #86 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 10.8%.
Is Erika Carmel-Tech's Days Payable too high?
Erika Carmel-Tech's current Days Payable of 506.96 is 69% above median its 10-year median of 299.13. Over the past 10 years, this metric has ranged from a low of 136.84 to a high of 422.75. The Medical Devices & Instruments industry median Days Payable is 67.85. Erika Carmel-Tech's value of 506.96 is 647.2% above this industry median. Based on the distribution chart, Erika Carmel-Tech ranks #86 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Erika Carmel-Tech has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Erika Carmel-Tech's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Erika Carmel-Tech ranks #86 out of 794 companies for Days Payable. This places Erika Carmel-Tech in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.85. Erika Carmel-Tech's value of 506.96 is 647.2% above this benchmark. Historically, Erika Carmel-Tech's own Days Payable has ranged from 136.84 to 422.75 over the past decade. While the company's 10-year median is 299.13 vs. the industry median of 67.85, Erika Carmel-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Erika Carmel-Tech's current Days Payable of 506.96 is 647.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Erika Carmel-Tech and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Erika Carmel-Tech's current Days Payable is 506.96, which is 69% above median its own 10-year median of 299.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Erika Carmel-Tech stock overvalued right now?
Based on GuruFocus' analysis, Erika Carmel-Tech (XTAE:ERKA) is currently considered Fairly Valued. The stock's GF Value™ is ₪0.55, compared to a current price of ₪0.52 — trading 6.4% below its estimated fair value. The current Days Payable is 506.96, which is 69% above median its 10-year median of 299.13 and 647.2% above the Medical Devices & Instruments industry median of 67.85. Erika Carmel-Tech's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Erika Carmel-Tech (XTAE:ERKA), the current Days Payable is 506.96 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Erika Carmel-Tech (XTAE:ERKA) Overvalued in 2026?
Based on GuruFocus' analysis, Erika Carmel-Tech stock appears to be undervalued.
The current stock price of ₪0.52 is trading 6.4% below its estimated GF Value™ of ₪0.55.
GuruFocus considers Erika Carmel-Tech to be Fairly Valued.
Key valuation signals for XTAE:ERKA:
Days Payable: 506.96 (69% above median its 10-year median of 299.13)
GF Value™: ₪0.55 vs. price of ₪0.52 (6.4% below fair value)
Industry Position: 647.2% above the Medical Devices & Instruments median (#86 of 794)
No single metric tells the full story. See the XTAE:ERKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Erika Carmel-Tech Ltd Formerly Erika B-Cure Laser Ltd is engaged in the development and production of laser devices for the treatment of pain and wounds. Its devices provide treatment for Knee Pain, Lower Back Pain, Neck Pain, Shoulder Pain, Finger Joint pain, and Burns.
32GF Score
Get the complete analysis for XTAE:ERKA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ERKA has been successfully added to your 
